Already a DIA Member? Sign in. Not a member? Join.

Iniciar sesión

¿Ha olvidado su ID de usuario? or ¿Ha olvidado su contraseña?

Not a Member?

Create Account and Join

Mercure Amsterdam City Hotel

08 nov 2023 8:30 a.m. - 09 nov 2023 5:15 p.m.

Joan Muyskenweg 10, 1096 CJ Amsterdam, Netherlands

Global Forum for Qualified Persons for Pharmacovigilance (QPPV)

This Forum provides valuable insights into the most pressing issues QPPVs are facing today. This event has limited capacity, register early!

Lunch And Learn (Sign-up required, spaces limited)

Session Chair(s)

Helen  Fiddes

Helen Fiddes

Head of Country Pharmacovigilance, UK and Ireland

United Kingdom

Elspeth  McIntosh, MBA, RN

Elspeth McIntosh, MBA, RN

Director

Castle Pharmacovigilance Ltd, United Kingdom

Willemijn  van der Spuij, MSc

Willemijn van der Spuij, MSc

Executive Director, WorldWide Patient Safety International, Europe

Switzerland

Maarten  Lagendijk, MSc

Maarten Lagendijk, MSc

Deputy EU QPPV

MSD, Netherlands

James  Whitehead, MBA, MSc

James Whitehead, MBA, MSc

Senior Director, Device & Digital Safety

AstraZeneca, United Kingdom

Sabine  Straus, MD, PhD, MSc

Sabine Straus, MD, PhD, MSc

Former PRAC Chair

Medicines Evaluation Board (MEB), Netherlands

Come and be part of our first-ever lunch and learn session! Enjoy a casual conversation during lunchtime about key topics covered throughout the day. Bring your meal to the table, engage with fellow participants, and converse with both session chairs and other attendees to share solutions, ideas, and insights. Plus, take this opportunity to foster new connections and contribute to the vibrant learning community we're building together.

(This event has limited spaces available and needs pre-registration)

Table 1: Medicine Shortages

Helen Fiddes, Head of Country Pharmacovigilance, UK and Ireland, Pharmacovigilance, BMS

Elspeth McIntosh, Director, Castle Pharmacovigilance Limited

Table 2: Keynote Discussion

Willemijn van der Spuij, Exec. Director Europe WorldWide Patient Safety, Bristol-Myers Squibb

Sabine Strauss, PRAC Chair, Staff Member, Medicines Evaluation Board (MEB)

Table 3 and 4: AI and Digitalization:

Maarten Lagendijk, Director, Deputy EU QPPV, MSD

James Whitehead, Patient Safety Medical Device Lead, Astrazeneca

¿Tiene una cuenta?

Be informed and stay engaged.

Don't miss an opportunity - join our mailing list to stay up to date on DIA insights and events.